US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GRAIL, Inc.

140.12

+3.552.60%

Pre-market: 140.500.3800+0.27%05:24 EDT

Volume:1.92M

Turnover:277.63M

Market Cap:6.26B

PE:-14.37

High:151.46

Open:138.27

Low:136.00

Close:136.57

52wk High:151.46

52wk Low:41.50

Shares:44.67M

Float Shares:40.70M

Volume Ratio:0.96

T/O Rate:4.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.7487

EPS(LYR):-11.1105

ROE:-16.12%

ROA:-12.03%

PB:2.46

PE(LYR):-12.61

Loading ...

Overview Company News Filings

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as AI Optimism Overshadows Middle East Risks

MT Newswires Live

GRAIL Shares Fall Pre-Bell After Galleri Trial Misses Primary Endpoint

MT Newswires Live

Canaccord Genuity Keeps Their Buy Rating on GRAIL Inc (GRAL)

Grail's Galleri Test Improves Cancer Detection in Pathfinder 2 Trial

MT Newswires Live

Grail presents ‘positive’ performance, safety results from Pathfinder 2 study

Grail reports results from NHS-Galleri trial in presentation at ASCO meeting

Grail Presents Pathfinder 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 Asco Annual Meeting

THOMSON REUTERS

BRIEF-Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction In Stage Iv Cancer Diagnoses

Grail - Galleri Blood Test Reduces Stage Iv Diagnoses by 22% in Second and 26% in Third Rounds

THOMSON REUTERS

Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction in Stage Iv Cancer Diagnoses at 2026 Asco Annual Meeting

THOMSON REUTERS

Grail Inc - No Reduction Observed in Combined Primary Endpoint of Stage Iii/Iv Cancers in Aggregate

THOMSON REUTERS

Grail grants 34,350 RSUs to 56 new hires under inducement equity plan

Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and GRAIL Inc (GRAL)

Grail to present at Goldman Sachs Global Healthcare Conference

Grail to present at Jefferies Global Healthcare Conference

Grail posts MCED study presentation on reducing emergency cancer diagnoses via ED

Grail Q1 net loss narrows 12% to $93.2 million; revenue rises 28% to $40.8 million

Grail price target lowered to $70 from $82 at Baird

GRAIL (GRAL) Q1 2026 Heavy US$93 Million Loss Tests High 16.5x Sales Multiple

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/GRAL/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":140.12,"timestamp":1790798400000,"preClose":136.57,"halted":0,"volume":1923794,"hourTrading":{"tag":"盘前","latestPrice":140.5,"preClose":140.12,"latestTime":"05:24 EDT","volume":1358,"amount":190091.98445999998,"timestamp":1790846690210,"change":0.38,"changeRate":0.002712,"amplitude":0.169489},"delay":0,"changeRate":0.025993995753093736,"floatShares":40696402,"shares":44666200,"eps":-9.748709,"marketStatus":"Pre-Mkt","change":3.55,"latestTime":"10-01 05:27:30 EDT","open":138.27,"high":151.4574,"low":136,"amount":277625751.73451996,"amplitude":0.113183,"askPrice":142.49,"askSize":50,"bidPrice":127.94,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-9.748709,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":140.12,"preHourTrading":{"tag":"盘前","latestPrice":140.5,"preClose":140.12,"latestTime":"05:24 EDT","volume":1358,"amount":190091.98445999998,"timestamp":1790846690210,"change":0.38,"changeRate":0.002712,"amplitude":0.169489},"postHourTrading":{"tag":"盘后","latestPrice":139.86,"preClose":140.12,"latestTime":"19:56 EDT","volume":32521,"amount":4558526.3976,"timestamp":1790812614555,"change":-0.26,"changeRate":-0.001856,"amplitude":0.00865},"volumeRatio":0.9586679187629507,"impliedVol":0.8926,"impliedVolPercentile":0.356},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":40696402,"roa":"-12.03%","roe":"-16.12%","lyrEps":-11.110457,"volumeRatio":0.9586679187629507,"shares":44666200,"dividePrice":0,"high":151.4574,"amplitude":0.113183,"preClose":136.57,"low":136,"week52Low":41.5,"pbRate":"2.46","psRate":"37.87","week52High":151.4574,"institutionHeld":0,"latestPrice":140.12,"committee":0.333333,"eps":-9.748709,"divideRate":0,"volume":1923794,"delay":0,"ttmEps":-9.748709,"open":138.27,"prevYearClose":85.59,"prevWeekClose":126.89,"prevMonthClose":140.12,"prevQuarterClose":140.12,"fiveDayClose":108.52,"twentyDayClose":79.79,"sixtyDayClose":68.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"GRAL","fiscalQuarterEnding":"2026/06","expectedEps":-2.91,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-2.56},{"market":"US","date":"2026-05-05","symbol":"GRAL","fiscalQuarterEnding":"2026/03","expectedEps":3,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2026-02-19","symbol":"GRAL","fiscalQuarterEnding":"2025/12","expectedEps":-3.33,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2025-11-12","symbol":"GRAL","fiscalQuarterEnding":"2025/09","expectedEps":-3.4,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-2.46},{"market":"US","date":"2025-08-12","symbol":"GRAL","fiscalQuarterEnding":"2025/06","expectedEps":-3.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-3.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1818,"buy":0.2727,"hold":0.5455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2727,"analysts":11,"updateTime":1789704000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2026-09-29","current":-14.373185,"percent":0,"low":-15.128394,"twenty":-7.781601,"median":-2.669291,"eighty":-0.303535,"high":-0.135365,"avg":-3.810123,"sd":3.691823,"marketCap":5924082615},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278},{"date":"2025-06-13","current":-0.787758,"twenty":-0.602918,"median":-0.308322,"eighty":-0.156041,"marketCap":1508008868},{"date":"2025-06-20","current":-0.910282,"twenty":-0.617043,"median":-0.310838,"eighty":-0.156127,"marketCap":1742556049},{"date":"2025-06-27","current":-0.927946,"twenty":-0.628237,"median":-0.313683,"eighty":-0.156967,"marketCap":1776371133},{"date":"2025-07-03","current":-0.87796,"twenty":-0.640897,"median":-0.324667,"eighty":-0.158949,"marketCap":1680681639},{"date":"2025-07-11","current":-0.815382,"twenty":-0.656882,"median":-0.33641,"eighty":-0.159595,"marketCap":1560889904},{"date":"2025-07-18","current":-0.675007,"twenty":-0.694504,"median":-0.351643,"eighty":-0.160456,"marketCap":1292167904},{"date":"2025-07-25","current":-0.746416,"twenty":-0.703946,"median":-0.35847,"eighty":-0.160672,"marketCap":1428867181},{"date":"2025-08-01","current":-0.642872,"twenty":-0.704698,"median":-0.372061,"eighty":-0.161318,"marketCap":1230653229},{"date":"2025-08-08","current":-0.619382,"twenty":-0.703946,"median":-0.384644,"eighty":-0.164764,"marketCap":1185686362},{"date":"2025-08-15","current":-2.618835,"twenty":-0.718416,"median":-0.412102,"eighty":-0.165733,"marketCap":1160018171},{"date":"2025-08-22","current":-2.697774,"twenty":-0.721799,"median":-0.415789,"eighty":-0.165949,"marketCap":1194984536},{"date":"2025-08-29","current":-2.7759,"twenty":-0.732698,"median":-0.419718,"eighty":-0.170579,"marketCap":1229590423},{"date":"2025-09-05","current":-2.733582,"twenty":-0.742958,"median":-0.427076,"eighty":-0.170837,"marketCap":1210845568},{"date":"2025-09-12","current":-3.145369,"twenty":-0.751941,"median":-0.435395,"eighty":-0.172539,"marketCap":1393247431},{"date":"2025-09-19","current":-3.221867,"twenty":-0.757193,"median":-0.443129,"eighty":-0.177083,"marketCap":1427132362},{"date":"2025-09-26","current":-3.927439,"twenty":-0.772199,"median":-0.450236,"eighty":-0.179927,"marketCap":1739666779},{"date":"2025-10-03","current":-5.267781,"twenty":-0.790326,"median":-0.453995,"eighty":-0.180724,"marketCap":2333374029},{"date":"2025-10-10","current":-5.788618,"twenty":-0.792794,"median":-0.466707,"eighty":-0.18193,"marketCap":2564079942},{"date":"2025-10-17","current":-7.032117,"twenty":-0.810572,"median":-0.474733,"eighty":-0.214168,"marketCap":3114890311},{"date":"2025-10-24","current":-6.726125,"twenty":-0.834423,"median":-0.483801,"eighty":-0.232186,"marketCap":2979350587},{"date":"2025-10-31","current":-7.417862,"twenty":-0.86879,"median":-0.497307,"eighty":-0.23482,"marketCap":3285756878},{"date":"2025-11-07","current":-6.515349,"twenty":-0.90953,"median":-0.508594,"eighty":-0.23627,"marketCap":2885986787},{"date":"2025-11-14","current":-7.32206,"twenty":-1.284423,"median":-0.515869,"eighty":-0.238888,"marketCap":3243320953},{"date":"2025-11-21","current":-8.218834,"twenty":-2.622741,"median":-0.524768,"eighty":-0.242438,"marketCap":3338827399},{"date":"2025-11-28","current":-10.592844,"twenty":-2.668803,"median":-0.533066,"eighty":-0.245748,"marketCap":4303247596},{"date":"2025-12-05","current":-10.047321,"twenty":-2.733908,"median":-0.545714,"eighty":-0.248685,"marketCap":4081633659},{"date":"2025-12-12","current":-9.121802,"twenty":-2.773947,"median":-0.559678,"eighty":-0.249586,"marketCap":3705650118},{"date":"2025-12-19","current":-8.474563,"twenty":-3.023948,"median":-0.565758,"eighty":-0.250383,"marketCap":3442715024},{"date":"2025-12-26","current":-8.814736,"twenty":-3.115583,"median":-0.600672,"eighty":-0.254281,"marketCap":3580907004},{"date":"2026-01-02","current":-8.213077,"twenty":-3.191837,"median":-0.607471,"eighty":-0.259493,"marketCap":3336488466},{"date":"2026-01-09","current":-9.407758,"twenty":-3.756539,"median":-0.615248,"eighty":-0.260321,"marketCap":3821817142},{"date":"2026-01-16","current":-9.350183,"twenty":-4.63773,"median":-0.618067,"eighty":-0.262044,"marketCap":3798427809},{"date":"2026-01-23","current":-11.136928,"twenty":-5.050494,"median":-0.621638,"eighty":-0.262589,"marketCap":4524276801},{"date":"2026-01-30","current":-9.689876,"twenty":-5.381714,"median":-0.623725,"eighty":-0.263657,"marketCap":3936424878},{"date":"2026-02-06","current":-9.025844,"twenty":-5.92371,"median":-0.62862,"eighty":-0.266328,"marketCap":3666667895},{"date":"2026-02-13","current":-9.201448,"twenty":-6.490935,"median":-0.634416,"eighty":-0.269888,"marketCap":3738005363},{"date":"2026-02-20","current":-10.027753,"twenty":-6.738169,"median":-0.640672,"eighty":-0.270458,"marketCap":4094842980},{"date":"2026-02-27","current":-5.738328,"twenty":-6.59852,"median":-0.642551,"eighty":-0.271707,"marketCap":2343252016},{"date":"2026-03-06","current":-5.1161,"twenty":-6.525603,"median":-0.645131,"eighty":-0.273298,"marketCap":2089164448},{"date":"2026-03-13","current":-4.454105,"twenty":-6.495818,"median":-0.656882,"eighty":-0.273627,"marketCap":1818838106},{"date":"2026-03-20","current":-4.868977,"twenty":-6.467497,"median":-0.678025,"eighty":-0.275336,"marketCap":1988251759},{"date":"2026-03-27","current":-5.23965,"twenty":-6.370491,"median":-0.694504,"eighty":-0.275763,"marketCap":2139616500},{"date":"2026-04-02","current":-5.384303,"twenty":-6.22661,"median":-0.703946,"eighty":-0.276019,"marketCap":2198685668},{"date":"2026-04-10","current":-4.777565,"twenty":-6.012578,"median":-0.718792,"eighty":-0.276332,"marketCap":1950923327},{"date":"2026-04-17","current":-4.969431,"twenty":-5.842655,"median":-0.720859,"eighty":-0.277189,"marketCap":2029272014},{"date":"2026-04-24","current":-5.087966,"twenty":-5.758444,"median":-0.724241,"eighty":-0.277697,"marketCap":2077675915},{"date":"2026-05-01","current":-5.472702,"twenty":-5.73481,"median":-0.732698,"eighty":-0.277887,"marketCap":2234783492},{"date":"2026-05-08","current":-6.830613,"twenty":-5.758444,"median":-0.740497,"eighty":-0.278585,"marketCap":2700312031},{"date":"2026-05-15","current":-6.709025,"twenty":-6.393277,"median":-0.747877,"eighty":-0.279728,"marketCap":2652245447},{"date":"2026-05-22","current":-7.366901,"twenty":-6.535065,"median":-0.752054,"eighty":-0.280426,"marketCap":2912320000},{"date":"2026-05-29","current":-8.024776,"twenty":-6.608933,"median":-0.75506,"eighty":-0.280871,"marketCap":3172394554},{"date":"2026-06-05","current":-7.224687,"twenty":-6.675155,"median":-0.757458,"eighty":-0.282109,"marketCap":2856099264},{"date":"2026-06-12","current":-6.530986,"twenty":-6.667338,"median":-0.770188,"eighty":-0.283378,"marketCap":2581862234},{"date":"2026-06-18","current":-6.453909,"twenty":-6.64758,"median":-0.774322,"eighty":-0.283727,"marketCap":2551391453},{"date":"2026-06-26","current":-7.226858,"twenty":-6.705551,"median":-0.790201,"eighty":-0.284901,"marketCap":2856957596},{"date":"2026-07-02","current":-7.394041,"twenty":-6.741593,"median":-0.791697,"eighty":-0.287059,"marketCap":2923049149},{"date":"2026-07-10","current":-8.227784,"twenty":-6.830613,"median":-0.793866,"eighty":-0.287218,"marketCap":3252648583},{"date":"2026-07-17","current":-7.811998,"twenty":-6.920316,"median":-0.805047,"eighty":-0.287691,"marketCap":3088278032},{"date":"2026-07-24","current":-7.638301,"twenty":-7.010823,"median":-0.819893,"eighty":-0.291185,"marketCap":3019611483},{"date":"2026-07-31","current":-7.722978,"twenty":-7.028862,"median":-0.830133,"eighty":-0.292962,"marketCap":3053086426},{"date":"2026-08-07","current":-7.231699,"twenty":-7.225121,"median":-0.842819,"eighty":-0.294422,"marketCap":2831839235},{"date":"2026-08-14","current":-7.783772,"twenty":-7.278539,"median":-0.870399,"eighty":-0.295212,"marketCap":3048023808},{"date":"2026-08-21","current":-8.893621,"twenty":-7.372329,"median":-0.87796,"eighty":-0.295699,"marketCap":3482626264},{"date":"2026-08-28","current":-9.410334,"twenty":-7.428129,"median":-0.917705,"eighty":-0.296146,"marketCap":3684964305},{"date":"2026-09-04","current":-9.195892,"twenty":-7.480979,"median":-0.966282,"eighty":-0.297019,"marketCap":3600991785},{"date":"2026-09-11","current":-8.846854,"twenty":-7.492831,"median":-2.572448,"eighty":-0.297976,"marketCap":3464313109},{"date":"2026-09-18","current":-9.119469,"twenty":-7.639447,"median":-2.628601,"eighty":-0.298484,"marketCap":3571065408},{"date":"2026-09-25","current":-14.282035,"twenty":-7.746291,"median":-2.668477,"eighty":-0.301515,"marketCap":5592659159},{"date":"2026-09-29","current":-15.128394,"twenty":-7.781601,"median":-2.669291,"eighty":-0.303535,"marketCap":5924082615}],"updateTime":1790807177975},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640195425","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as AI Optimism Overshadows Middle East Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640195425","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640195425?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:03","pubTimestamp":1780318990,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.2% in Monday's premarket activity, as enthusiasm for new artif","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RTH.AU","IYE","AIPO","VG","GNK","SOXX","IBB","OP.USD.HKCC","QQQ","XLY","XRT","XLP","VHT","IYJ","COIN","SLV","XLE","SPY","EETH","UNG","XLF","XSD","TMHC","FAS","VIS","IYW","FAZ","XLV","USO","GLD","IGM","VHT.AU","XLK","GRAL","FDN","AGIX","DELL","RTH","VDC","IYH","CHAT","SPY.AU","IVV","IYK","BITO","ARTY","EQR","XLI","DSX","BETH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951996","title":"GRAIL Shares Fall Pre-Bell After Galleri Trial Misses Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951996","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951996?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:26","pubTimestamp":1780316761,"startTime":"0","endTime":"0","summary":"GRAIL's  stock fell 11% in Monday's premarket session after the company said over the weekend that the NHS-Galleri trial of its Galleri multi-cancer early detection test missed its primary endpoint.The NHS-Galleri trial evaluated a primary endpoint of Stage III and IV diagnoses in a group of 12 cancers. The company said that when the Galleri test was added to standard of care screening in England, there was no statistically significant difference one year following the participants' last appointment.\"The NHS-Galleri trial tested whether adding the Galleri blood test to NHS screening could reduce the combined number of cancers diagnosed at Stage III or IV over three years,\" Charles Swanton, one of the trial's chief investigators, said in a statement. \"The primary endpoint was not met.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959470","title":"Canaccord Genuity Keeps Their Buy Rating on GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959470","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959470?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:57","pubTimestamp":1780315054,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Kyle Mikson CFA reiterated a Buy rating on GRAIL Inc today and set a price target of $80.00. According to TipRanks, Mikso...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640372359","title":"Grail's Galleri Test Improves Cancer Detection in Pathfinder 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640372359","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640372359?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:22","pubTimestamp":1780305773,"startTime":"0","endTime":"0","summary":"Grail's  Galleri multi-cancer early detection blood test significantly improved detection when used alongside standard screenings in adults aged 50 and older, as shown by results from the Pathfinder 2 study, the company said over the weekend.The company said adding Galleri to recommended screenings increased cancer detection 6.5-fold, with 71% of newly identified cancers detected at stages I to III and more than half detected at stages I or II.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","GRAL","BK4139","PBHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640431986","title":"Grail presents ‘positive’ performance, safety results from Pathfinder 2 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640431986","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640431986?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:43","pubTimestamp":1780263811,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that “positive” performance and safety results from the analysis of the full 35,878 cohort of its registrational Pathfinder ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-presents-positive-performance-safety-results-from-pathfinder-2-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-presents-positive-performance-safety-results-from-pathfinder-2-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","PBHC","BK4139","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986135","title":"Grail reports results from NHS-Galleri trial in presentation at ASCO meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640986135?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:36","pubTimestamp":1780263408,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced detailed clinical utility, performance and safety results from its NHS-Galleri trial in an oral presentation at the 2026 Ame...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-reports-results-from-nhs-galleri-trial-in-presentation-at-asco-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-reports-results-from-nhs-galleri-trial-in-presentation-at-asco-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639798832","title":"Grail Presents Pathfinder 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 Asco Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639798832","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639798832?lang=en_us&edition=fundamental","pubTime":"2026-05-31 20:00","pubTimestamp":1780228801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nTUA4BNHYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639360952","title":"BRIEF-Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction In Stage Iv Cancer Diagnoses","url":"https://stock-news.laohu8.com/highlight/detail?id=2639360952","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639360952?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:14","pubTimestamp":1780143259,"startTime":"0","endTime":"0","summary":"BRIEF-Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction In Stage Iv Cancer Diagnoses May 30 (Reuters) - Grail Inc GRAL.O:GRAIL REPORTS FULL RESULTS FROM NHS-GALLERI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA1KXBZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609588","title":"Grail - Galleri Blood Test Reduces Stage Iv Diagnoses by 22% in Second and 26% in Third Rounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609588?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA1KXBZY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639301609","title":"Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction in Stage Iv Cancer Diagnoses at 2026 Asco Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639301609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639301609?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA1KXBZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639260953","title":"Grail Inc - No Reduction Observed in Combined Primary Endpoint of Stage Iii/Iv Cancers in Aggregate","url":"https://stock-news.laohu8.com/highlight/detail?id=2639260953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639260953?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA1KXBZY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638306635","title":"Grail grants 34,350 RSUs to 56 new hires under inducement equity plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2638306635","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638306635?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:01","pubTimestamp":1779912081,"startTime":"0","endTime":"0","summary":"Grail granted restricted stock units covering 34,350 shares to 56 recently hired non-executive employees.RSUs vest over about four years; 25% vests May 31, 2027, then on each one-year anniversary, subject to continued employment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL2t999r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638163535","title":"Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638163535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638163535?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:01","pubTimestamp":1779912060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUAFHWFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638062785","title":"Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638062785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638062785?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:01","pubTimestamp":1779876067,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ICU Medical (ICUI) and GRAIL Inc (GRAL) with bullish...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-icu-medical-icui-and-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-icu-medical-icui-and-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0106261612.USD","BK4588","LU0205194284.USD","SG9999015945.SGD","SG9999015952.SGD","GRAL","BK4198","LU0128526141.USD","LABU","BK4139","LU0029874061.USD","SG9999015978.USD","BK4581","LU0205193047.USD","BK4137","LU0012050646.USD","SG9999015986.USD","XLV","XBI","ICU","LU0240878834.USD","ICUI","HCSG","BK4082","LU0240877869.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638854035","title":"Grail to present at Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638854035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638854035?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:01","pubTimestamp":1779825686,"startTime":"0","endTime":"0","summary":"Grail management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami on June 9 at 11:20 a.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL8kKCMH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","BK4585","LU0742534661.SGD","LU2750360997.AUD","GSX","LU2237443382.USD","LU2471134523.USD","LU0106831901.USD","LU2471134796.USD","LU0048573561.USD","LU2237438978.USD","IE0004086264.USD","IE00B19Z3B42.SGD","IE00BFXG1179.USD","GRAL","LU1868836914.USD","IE00BSNM7G36.USD","LU1894683264.USD","LU1894683348.USD","BK4127","LU2265009873.SGD","LU0251131958.USD","BK4552","IE0002270589.USD","LU1868836591.USD","LU2237443978.SGD","LU2471134879.HKD","LU1868836757.USD","LU2237443465.HKD","LU0345770308.USD","LU0345770993.USD","LU0868494708.USD","LU1804176565.USD","LU2237443549.SGD","LU0061475181.USD","LU0942090050.USD","IE0034235188.USD","LU1868837136.USD","LU1868837300.USD","BK4139","LU2237443622.USD","LU2237443895.HKD","LU2471134952.CNY","LU0096364046.USD","BK4516","BK4533","IE0004091025.USD","LU1791807156.HKD","BK4504","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637351925","title":"Grail to present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2637351925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637351925?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:01","pubTimestamp":1779393690,"startTime":"0","endTime":"0","summary":"Grail management is scheduled to present at the Jefferies Global Healthcare Conference in New York on June 3 at 7:35 a.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL8bPLb5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636835828","title":"Grail posts MCED study presentation on reducing emergency cancer diagnoses via ED","url":"https://stock-news.laohu8.com/highlight/detail?id=2636835828","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636835828?lang=en_us&edition=fundamental","pubTime":"2026-05-19 15:41","pubTimestamp":1779176479,"startTime":"0","endTime":"0","summary":"Grail released a medical research poster evaluating how multi-cancer early detection blood testing could reduce emergency department involvement at cancer diagnosis in a modeled Medicare-age screening cohort.The analysis projected a 51% overall reduction in cancers diagnosed with ED involvement versus usual care, with larger reductions in later-stage disease, including 61% in stage III and 70% in stage IV.The model estimated that incorporating ED avoidance increased gains from screening to 0.18 life years and 0.13 QALYs per person screened, up from 0.12 life years and 0.09 QALYs when only stage shift effects were counted.ED avoidance accounted for 31% of projected QALY gains, with the remainder attributed to stage shift, supporting a broader value case for MCED screening beyond earlier-stage detection alone.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gene","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL5DRVTC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633172039","title":"Grail Q1 net loss narrows 12% to $93.2 million; revenue rises 28% to $40.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633172039","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633172039?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:51","pubTimestamp":1778187103,"startTime":"0","endTime":"0","summary":"Grail posted a net loss of USD 93.19 million, narrowing from a year earlier, while operating loss tightened to USD 135.77 million.Revenue rose 28% to USD 40.79 million, driven by a 37% climb in screening revenue to USD 39.83 million.Development services revenue dropped 65% to USD 953,000, while cost of screening revenue excluding intangible amortization increased 24% to USD 21.24 million.Adjusted EBITDA improved to a loss of USD 79.92 million, while cash and cash equivalents totaled USD 69.3 million alongside USD 753.8 million in short-term marketable securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL9ZMZqD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633111627","title":"Grail price target lowered to $70 from $82 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2633111627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633111627?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:18","pubTimestamp":1778145518,"startTime":"0","endTime":"0","summary":"Baird lowered the firm’s price target on Grail (GRAL) to $70 from $82 and keeps an Outperform rating on the shares. The firm updated its model foll...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-price-target-lowered-to-70-from-82-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-price-target-lowered-to-70-from-82-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633973651","title":"GRAIL (GRAL) Q1 2026 Heavy US$93 Million Loss Tests High 16.5x Sales Multiple","url":"https://stock-news.laohu8.com/highlight/detail?id=2633973651","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633973651?lang=en_us&edition=fundamental","pubTime":"2026-05-07 14:39","pubTimestamp":1778135944,"startTime":"0","endTime":"0","summary":"GRAIL (NasdaqGS:GRAL) Q1 2026 Results in Focus\nGRAIL (NasdaqGS:GRAL) opened 2026 with Q1 revenue of US$40.8 million, a basic EPS loss of US$2.29 and net income loss of US$93.2 million, setting a cautious tone against a share price of US$62.75. Over recent quarters the company has seen revenue move from US$31.8 million in Q1 2025 to US$40.8 million in Q1 2026. Quarterly basic EPS losses have ranged between US$2.29 and US$3.18, keeping the spotlight firmly on how quickly the business model can...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-q1-2026-heavy-us93-million-loss-tests-high-165x-s","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-q1-2026-heavy-us93-million-loss-tests-high-165x-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":121,"code":"91000000","status":"200"}]}}